Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-09-000141
Filing Date
2009-02-05
Accepted
2009-02-05 17:40:09
Documents
2
Period of Report
2009-01-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 8981
2 poazabriskie.htm EX-24 5149
  Complete submission text file 0001123292-09-000141.txt   16365
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 40 WASHINGTON STREET SUITE 220 WELLESLEY HILLS MA 02481
Business Address 110 HARTWELL AVE LEXINGTON MA 02173 781-489-7310
ZABRISKIE JOHN L (Reporting) CIK: 0001128329 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 09574127
SIC: 2834 Pharmaceutical Preparations